Close Window

Digital Look Email A Friend

Merck&Co. says oral Covid-19 treatment cuts risk of hospitalisation or death by 30%

Published by Alexander Bueso on 26th November 2021

(Sharecast News) - Merck&Co. and development partner Ridgeback Biotherapeutics announced that their experimental oral treatment against Covid-19 reduced the risk of hospitalisation or death by nearly one third.

URL: http://www.digitallook.com/dl/news/story/32292448/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.